US Pat. No. 10,213,438

ALKALOID COMPOUNDS FOR TREATING DEPRESSION, SUBSTANCE ADDICTIONS, AND INDICATIONS ASSOCIATED WITH CHRONIC INFLAMMATION

MyMD Pharmaceuticals, Inc...

1. A compound selected from the group consisting of:
2-Pyridin-3-yl-2,3,4,7-tetrahydro-1H-azepine and 2-Pyridin-3-yl-2,3,6,7-tetrahydro-1H-azepine
or a pharmaceutically acceptable salt thereof.

US Pat. No. 9,884,055

METHOD OF TREATING SUBSTANCE ADDICTIONS

MyMD Pharmaceuticals, Inc...

1. A method of treating a tobacco addiction comprising administering to an individual in need thereof a pharmaceutical composition
comprising a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically
acceptable vehicle therefor, wherein said effective amount reduces or eliminates craving for nicotine or dependence on nicotine.

US Pat. No. 10,471,052

METHOD OF TREATING ADDICTIONS TO OPIOIDS

MyMD Pharmaceuticals, Inc...

1. A method of treating an addiction to opioids comprising administering to an individual in need thereof a pharmaceutical composition comprising a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
US Pat. No. 10,588,899

METHODS OF TREATING DIABETES

MyMD Pharmaceuticals, Inc...

1. A method of treating diabetes comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
US Pat. No. 10,517,856

METHODS OF ALTERING PROGRAMMED CELL DEATH AND EXTENDING CELL LIFE

MyMD Pharmaceuticals, Inc...

1. A method of altering programmed cell death in an individual comprising administering to the individual a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
US Pat. No. 10,918,633

METHOD OF TREATING CORONAVIRUS

MyMD Pharmaceuticals, Inc...

1. A method of modulating an anti-inflammatory counteractive response characterized by release of cytokines in an individual suffering from a viral infection, the method comprising administering to the individual a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
US Pat. No. 10,835,523

METHOD OF REGULATING TUMOR NECROSIS FACTOR-ALPHA (TNF-?) FOR TREATING CANCERS, AUTOIMMUNE DISORDERS, AND OTHER DISORDERS ASSOCIATED WITH CHRONIC INFLAMMATION

MyMD Pharmaceuticals, Inc...

1. A method of regulating tumor necrosis factor-alpha (TNF-?) for treating a disorder associated with chronic inflammation comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
US Pat. No. 10,806,728

PHARMACEUTICAL SALTS OF ISOMYOSMINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

MyMD Pharmaceuticals, Inc...

1. A pharmaceutical salt of isomyosmine wherein the salt is selected from the group consisting of 1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-hydroxyethane sulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4-aminosalicylic acid, acetic acid, adipic acid, ascorbic acid (L), aspartic acid (L), benzenesulfonic acid, benzoic acid, camphoric acid (+), camphor-10-sulfonic acid (+), capric acid (decanoic acid), caproic acid (hexanoic acid), caprylic acid (octanoic acid), carbonic acid, cinnamic acid, citric acid, cyclamic acid, dodecyl sulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, formic acid, fumaric acid, galactaric acid, gentisic acid, glucoheptonic acid (D), gluconic acid (D), glucuronic acid (D), glutamic acid, glutaric acid, glycerophosphoric acid, glycolic acid, hippuric acid, hydrobromic acid, hydrochloric acid, isobutyric acid, lactic acid (DL), lactobionic acid, lauric acid, maleic acid, malic acid (?L), malonic acid, mandelic acid (DL), methanesulfonic acid, naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, nicotinic acid, nitric acid, oleic acid, oxalic acid, palmitic acid, pamoic acid, phosphoric acid, proprionic acid, pyroglutamic acid (?L), salicylic acid, sebacic acid, stearic acid, succinic acid, sulfuric acid, tartaric acid (+L), thiocyanic acid, toluenesulfonic acid (p), and undecylenic acid.
US Pat. No. 10,786,493

METHOD OF TREATING VIRAL INFECTIONS

MyMD Pharmaceuticals, Inc...

1. A method of treating a viral infection comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
US Pat. No. 10,722,506

METHOD OF TREATING MULTIPLE SCLEROSIS

MyMD Pharmaceuticals, Inc...

1. A method of treating multiple sclerosis comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.